A national study on long-term osteoporosis therapy and risk of recurrent fractures in patients with hip fracture

Abrahamsen, 2009, Excess mortality following hip fracture: A systematic epidemiological review, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 20, 1633, 10.1007/s00198-009-0920-3 Baba, 2015, Inadequate management for secondary fracture prevention in patients with distal radius fracture by trauma surgeons, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 26, 1959, 10.1007/s00198-015-3103-4 Brunner, 2003, Hip fractures in adults, American Family Physician, 67, 537 Center, 2011, Osteoporosis medication and reduced mortality risk in elderly women and men, The Journal of Clinical Endocrinology and Metabolism, 96, 1006, 10.1210/jc.2010-2730 Chan, 2014, Validation study of Charlson Comorbidity Index in predicting mortality in Chinese older adults, Geriatrics & Gerontology International, 14, 452, 10.1111/ggi.12129 Chen, 2017, Secular trends in incidence and recurrence rates of hip fracture: A nationwide population-based study, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 28, 811, 10.1007/s00198-016-3820-3 Cheung, 2016, Osteoporosis in East Asia: Current issues in assessment and management, Osteoporosis and Sarcopenia, 2, 118, 10.1016/j.afos.2016.07.001 Cheung, 2018, An updated hip fracture projection in Asia: The Asian Federation of Osteoporosis Societies study, Osteoporosis and Sarcopenia, 4, 16, 10.1016/j.afos.2018.03.003 Cheung, 2018, Post-fracture care gap: A retrospective population-based analysis of Hong Kong from 2009 to 2012, Hong Kong Medical Journal, 24, 579 Compston, 2013, Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013, Maturitas, 75, 392, 10.1016/j.maturitas.2013.05.013 Cooper, 2011, Secular trends in the incidence of hip and other osteoporotic fractures, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 22, 1277, 10.1007/s00198-011-1601-6 Degli Esposti, 2018, Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: Impact on re-fracture and mortality risk, Endocrine Deyo, 1992, Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases, Journal of Clinical Epidemiology, 45, 613, 10.1016/0895-4356(92)90133-8 Gamboa, 2018, Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 29, 2309, 10.1007/s00198-018-4622-6 Gillette, 2015, Medication persistence in older women with osteoporosis: A pilot study, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 26, 2883, 10.1007/s00198-015-3242-7 Gluszko, 2014, Polish guidelines for the diagnosis and management of osteoporosis: A review of 2013 update, Polish Archives of Internal Medicine, 124, 255, 10.20452/pamw.2255 Gonnelli, 2017, Prescription of anti-osteoporosis medications after hospitalization for hip fracture: A multicentre Italian survey, Aging Clinical and Experimental Research, 29, 1031, 10.1007/s40520-016-0681-8 Gonzalez-Zabaleta, 2016, Comorbidity as a predictor of mortality and mobility after hip fracture, Geriatrics & Gerontology International, 16, 561, 10.1111/ggi.12510 Gullberg, 1997, World-wide projections for hip fracture, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 7, 407, 10.1007/PL00004148 Hernlund, 2013, Osteoporosis in the European Union: Medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA), Archives of Osteoporosis, 8, 136, 10.1007/s11657-013-0136-1 Holloway, 2015, Prior fracture as a risk factor for future fracture in an Australian cohort, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 26, 629, 10.1007/s00198-014-2897-9 Hsing, 2015, Nationwide population science: Lessons from the Taiwan national health insurance research database, JAMA Internal Medicine, 175, 1527, 10.1001/jamainternmed.2015.3540 Hsu, 2015, Medical specialty-related adherence to anti-osteoporotic regimens in fragility hip fracture patients, Journal of Bone and Mineral Metabolism, 33, 577, 10.1007/s00774-014-0621-7 Hu, 2012, Preoperative predictors for mortality following hip fracture surgery: A systematic review and meta-analysis, Injury, 43, 676, 10.1016/j.injury.2011.05.017 Johansson, 2017, Imminent risk of fracture after fracture, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 28, 775, 10.1007/s00198-016-3868-0 Johnell, 1997, The socioeconomic burden of fractures: Today and in the 21st century, The American Journal of Medicine, 103, 20S, 10.1016/S0002-9343(97)90023-1 Kanis, 2004, Excess mortality after hospitalisation for vertebral fracture, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 15, 108, 10.1007/s00198-003-1516-y Kannegaard, 2010, Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival, Age and Ageing, 39, 203, 10.1093/ageing/afp221 Klotzbuecher, 2000, Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis, Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research, 15, 721, 10.1359/jbmr.2000.15.4.721 Langdahl, 2018, Treatment of osteoporosis: Unmet needs and emerging solutions, Journal of Bone Metabolism, 25, 133, 10.11005/jbm.2018.25.3.133 Liu, 2018, Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis, Osteoporosis International, 29, 2409, 10.1007/s00198-018-4630-6 Liu, 2015, Meta-analysis of osteoporosis: Fracture risks, medication and treatment, Minerva Medica, 106, 203 Lyles, 2007, Zoledronic acid and clinical fractures and mortality after hip fracture, The New England Journal of Medicine, 357, 1799, 10.1056/NEJMoa074941 McLellan, 2003, The fracture liaison service: Success of a program for the evaluation and management of patients with osteoporotic fracture, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 14, 1028, 10.1007/s00198-003-1507-z Mnatzaganian, 2012, Accuracy of hospital morbidity data and the performance of comorbidity scores as predictors of mortality, Journal of Clinical Epidemiology, 65, 107, 10.1016/j.jclinepi.2011.03.014 Neuner, 2012, The importance of physicians’ risk perception in osteoporosis treatment decision making, Journal of Clinical Densitometry, 15, 49, 10.1016/j.jocd.2011.07.008 Peng, 2016, Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: A meta-analysis, Pakistan Journal of Medical Sciences, 32, 499 Qaseem, 2017, Treatment of low bone density or osteoporosis to prevent fractures in men and women: A clinical practice guideline update from the American college of physicians, Annals of Internal Medicine, 166, 818, 10.7326/M15-1361 Sampson, 2002, Alcohol and other factors affecting osteoporosis risk in women, Alcohol Research & Health: the Journal of the National Institute on Alcohol Abuse and Alcoholism, 26, 292 Simonelli, 2002, Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons, Mayo Clinic Proceedings, 77, 334, 10.4065/77.4.334 Souza, 2008, The Charlson comorbidity index (CCI) for adjustment of hip fracture mortality in the elderly: Analysis of the importance of recording secondary diagnoses, Cad Saude Publica, 24, 315, 10.1590/S0102-311X2008000200010 Spechbach, 2019, Higher rates of osteoporosis treatment initiation and persistence in patients with newly diagnosed vertebral fracture when introduced in inpatients than later in outpatients, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 30, 1353, 10.1007/s00198-019-04900-3 Tsukutani, 2015, Epidemiology of fragility fractures in Sakaiminato, Japan: Incidence, secular trends, and prognosis, Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 26, 2249, 10.1007/s00198-015-3124-z van Geel, 2018, Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study, PloS One, 13, 10.1371/journal.pone.0198006 Wang, 2013, Excess mortality after hip fracture among the elderly in Taiwan: A nationwide population-based cohort study, Bone, 56, 147, 10.1016/j.bone.2013.05.015 Wang, 2017, Age- and gender-specific epidemiology, treatment patterns, and economic burden of osteoporosis and associated fracture in Taiwan between 2009 and 2013, Archives of Osteoporosis, 12, 92, 10.1007/s11657-017-0385-5 Xia, 2012, Rapidly increasing rates of hip fracture in Beijing, China, Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research, 27, 125, 10.1002/jbmr.519 Yu, 2013, Non-adherence to anti-osteoporotic medications in Taiwan: Physician specialty makes a difference, Journal of Bone and Mineral Metabolism, 31, 351, 10.1007/s00774-013-0424-2 Yu, 2017, Access to anti-osteoporosis medication after hip fracture in korean elderly patients, Maturitas, 103, 54, 10.1016/j.maturitas.2017.06.021